DePuy Synthes Launches ViviGen Formable(TM) Cellular Bone Matrix, Providing a New Cellular Allograft with Alternative Consistency for Spinal Fusion Surgery
RAYNHAM, Mass., Feb. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Today, DePuy Synthes*, in collaboration with LifeNet Health®, launches ViviGen Formable Cellular Bone Matrix**, a second generation cellular allograft used to assist in the fo... Devices, Orthopaedic, Neurosurgery, Product Launch DePuy Synthes, Johnson & Johnson, LifeNet Health, ViviGen Formable
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Bone Graft | Brain | Marketing | Neurology | Neurosurgery | Orthopaedics | Pharmaceuticals